Cervical cancer continues to rank among the leading causes of cancer morbidity and mortality in women worldwide, underscoring the urgent need for innovative non-invasive, objective, and highly sensitive diagnostic methodologies, particularly for the early identification of lesions associated with the human papillomavir...
E. Rimskaya, N. Nazarova, Anastasia R. Devyatkina et al.· Gynecology· 0 citations
Malignant and benign mammary gland diseases (MG) are leading causes of female oncological and hormone-dependent pathology. The mammalogical safety of combined hormonal contraceptives (CHCs) remains under debate, underscoring the need for regimens that minimally affect MG tissue proliferation and breast cancer (BC) risk...
V. Prilepskaya, M. V. Iurova· Gynecology· 0 citations
Human papillomavirus (HPV) represents the most prevalent sexually transmitted infection worldwide. According to data from the World Health Organization, over 290 million women globally are infected, with prevalence rates among sexually active individuals ranging from 50% to 80%. The high prevalence of oncogenic HPV sig...
A. Mgeryan, A. Timofeeva, P. Abakarova et al.· Gynecology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
